The prognostic impact of plasma methylated HOXA9 in patients with advanced non-small cell lung cancer.

被引：0
作者：
Christensen, Sara Witting
Hansen, Torben
Nyhus, Christa Haugaard
Hager, Henrik
Hilberg, Ole
Andersen, Rikke Fredslund
Jakobsen, Anders Kristian Moeller
机构：
[1] Vejle Hosp, Dept Oncol, Vejle, Denmark
[2] Univ Southern Denmark, Inst Reg Hlth Res, Vejle Hosp, Dept Oncol, Vejle, Denmark
[3] Vejle Hosp, Dept Clin Pathol, Vejle, Denmark
[4] Vejle Hosp, Dept Internal Med, Vejle, Denmark
[5] Vejle Hosp, Dept Clin Biochem, Vejle, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24063
引用
收藏
页数：1
相关论文
共 50 条
[31]   Minority patients in clinical trials (CT) for advanced non-small cell lung cancer. [J].
Obasaju, CK ;
Catalano, RB ;
Marinucci, DM ;
Bloss, JD ;
Taylor, L ;
Monberg, MJ ;
Comis, RL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :658S-658S
[32]   Access to specialist care and treatment in patients with advanced non-small cell lung cancer. [J].
Ganti, Apar Kishor ;
Borghaei, Hossein ;
Hirsch, Fred R. ;
Wynes, Murry ;
Ravelo, Arliene ;
Ionescu-Ittu, Raluca ;
Pivneva, Irina ;
Ramalingam, Suresh S. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[33]   Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer. [J].
Karabou, Abdoulaye ;
Bisseux, Laurence ;
Pavese, Ida ;
Collon, Thierry .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[34]   Neoadjuvant therapy in non-small cell lung cancer. Prognostic impact of "mediastinal downstaging" - Commentary [J].
Dienemann, H .
CHIRURG, 2003, 74 (01) :49-49
[35]   Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy [J].
Rocco, Danilo ;
Della Gravara, Luigi ;
Ragone, Angela ;
Sapio, Luigi ;
Naviglio, Silvio ;
Gridelli, Cesare .
CANCERS, 2023, 15 (19)
[36]   Prognostic Factors Affecting Survival in Advanced Non-Small Cell Lung Cancer Patients [J].
Songur, Necla ;
Kuru, Bekir ;
Ok, Ugur .
TURKISH THORACIC JOURNAL, 2005, 6 (02) :91-97
[37]   Clinical Prognostic Model for Older Patients with Advanced Non-Small Cell Lung Cancer [J].
Ganti, A. K. ;
Wang, X. ;
Stinchcombe, T. ;
Wang, Y. ;
Kelly, K. ;
Paulus, R. ;
Bradley, J. ;
Ramalingam, S. ;
Cohen, H. ;
Vokes, E. ;
Pang, H. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S1878-S1879
[38]   A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer [J].
Ulas, Arife ;
Turkoz, Fatma Paksoy ;
Silay, Kamile ;
Tokluoglu, Saadet ;
Avci, Nilufer ;
Oksuzoglu, Berna ;
Alkis, Necati .
PLOS ONE, 2014, 9 (12)
[39]   Prognostic factors in older patients with advanced non-small cell lung cancer in China [J].
Su, Qiang ;
Sun, Yu-Ping ;
Liu, Ye-Hui ;
Li, Zhe ;
Yang, Hong-Yan ;
Sun, Zhi-Gang ;
Cao, Bang-Wei ;
Jia, Ji-Hui .
TUMORI, 2014, 100 (01) :69-74
[40]   Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients [J].
Wang, Chin-Chou ;
Tseng, Chia-Cheng ;
Chang, Huang-Chih ;
Huang, Kuo-Tung ;
Fang, Wen-Feng ;
Chen, Yu-Mu ;
Yang, Cheng-Ta ;
Hsiao, Chang-Chun ;
Lin, Meng-Chih ;
Ho, Chi-Kung ;
Yip, Hon-Kan .
ONCOTARGET, 2017, 8 (44) :75952-75967
12345